Frontline Spot On Dog

Страна: Ирландия

Язык: английский

Источник: HPRA (Health Products Regulatory Authority)

Купи это сейчас

Активный ингредиент:

Fipronil

Доступна с:

Merial Animal Health Limited

код АТС:

QP53AX15

ИНН (Международная Имя):

Fipronil

дозировка:

10 percent weight/volume

Фармацевтическая форма:

Spot-on solution

Тип рецепта:

POM: Prescription Only Medicine as defined in relevant national legislation

Терапевтическая группа:

Dogs

Терапевтические области:

fipronil

Терапевтические показания :

Ectoparasiticide

Статус Авторизация:

Authorised

Дата Авторизация:

1998-06-12

Характеристики продукта

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Frontline Spot On Dog.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Spot-on solution.
Clear to light brownish-yellow solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The treatment and prevention of infestations by fleas and ticks in
dogs.
Frontline Spot On Dog
has been shown to significantly reduce the incidence of Flea Allergy
Dermatitis.
Ticks will
usually detach from the treated host within 24 to 48 hours after
infestation, without having had a
blood meal.
Frontline Spot On Dog rapidly controls infestations with_ Trichodectes
canis_ (biting lice) on dogs.
4.3 CONTRAINDICATIONS
In the absence of available data, the product should not be used on
puppies less than 8 weeks
old and/or weighing less than 2 kg.
Do not use on sick (systemic diseases, fever….) or convalescent
animals.
Do not use in rabbits, as adverse reactions and even death could
occur.
This product is specifically developed for dogs. Do not use in cats,
as this could lead to
overdosing.
Each pipette contains:
Active Substance
Fipronil
10
% w/v
Excipients
Butylhydroxyanisole (E320) 0.02 % w/v
Butylhydroxytoluene (E321)
0.01 % w/v
Non-aqueous vehicle q.s. to
100 % w/v
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_0_
_/_
_0_
_2_
_/_
_2_
_0_
_1_
_4_
_C_
_R_
_N_
_ _
_7_
_0_
_1_
_7_
_2_
_1_
_0_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
                                
                                Прочитать полный документ
                                
                            

Поиск оповещений, связанных с этим продуктом

Просмотр истории документов